BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 20708032)

  • 1. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
    Dowie MJ; Scotter EL; Molinari E; Glass M
    Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease.
    Roze E; Bonnet C; Betuing S; Caboche J
    Adv Exp Med Biol; 2010; 685():45-63. PubMed ID: 20687494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Strategies for Huntington's Disease.
    Mrzljak L; Munoz-Sanjuan I
    Curr Top Behav Neurosci; 2015; 22():161-201. PubMed ID: 24277342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease: From molecular basis to therapeutic advances.
    Krobitsch S; Kazantsev AG
    Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease: clinical presentation and treatment.
    Novak MJ; Tabrizi SJ
    Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Huntington's disease: cellular and molecular basis of pathology].
    Korzhova VV; Artamonov DN; Vlasova OL; Bezprozvannyĭ IB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(4):359-75. PubMed ID: 25723022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foundation-directed therapeutic development in Huntington's disease.
    Dominguez C; Munoz-Sanjuan I
    J Med Chem; 2014 Jul; 57(13):5479-88. PubMed ID: 24432836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R; Atwal RS; Burtnik A
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.
    Wright DJ; Renoir T; Gray LJ; Hannan AJ
    Adv Neurobiol; 2017; 15():93-128. PubMed ID: 28674979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Borrell-Pagès M; Zala D; Humbert S; Saudou F
    Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
    Lorincz MT; Zawistowski VA
    Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease: from molecular pathogenesis to clinical treatment.
    Ross CA; Tabrizi SJ
    Lancet Neurol; 2011 Jan; 10(1):83-98. PubMed ID: 21163446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease.
    Waldvogel HJ; Thu D; Hogg V; Tippett L; Faull RL
    Adv Exp Med Biol; 2012; 769():141-52. PubMed ID: 23560309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's disease: seeing the pathogenic process through a genetic lens.
    Gusella JF; MacDonald ME
    Trends Biochem Sci; 2006 Sep; 31(9):533-40. PubMed ID: 16829072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.